Vitreous prolapse and IOL dislocation during intravitreal injection of triamcinolone acetonide |
| |
Authors: | Robert F. Degenring Gangolf Sauder |
| |
Affiliation: | (1) Department of Ophthalmology Cologne-Merheim, Cologne Hospitals, Ostmerheimer Str. 200, 51109 Cologne, Germany;(2) Department of Ophthalmology, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Heidelberg, Germany |
| |
Abstract: | Background To report on procedure-related anterior segment complications during intravitreal injections.Methods In a prospective interventional case series, 614 eyes received a total of 723 intravitreal injections of about 20 mg triamcinolone acetonide (in 0.2 ml) after paracentesis and aqueous humor drainage for various indications.Results In three eyes (0.49% of all eyes) a vitreous prolapse occurred during the injection. In one eye, the vitreous prolapse was combined with dislocation of the intraocular lens (IOL). All three eyes were pseudophakic, showing an posterior capsule defect, and the IOL located in the ciliary sulcus. They were treated by translimbal vitrectomy, and one eye with reposition of the IOL. No other procedure-related postoperative complications were observed during injection or follow-up (7.8±7.1 months).Conclusions Intravitreal injections may cause a vitreous prolapse into the anterior chamber with or without IOL decentration or dislocation in predisposed eyes. Ophthalmologists should be aware of this possible complication and inform patients at risk.None of the authors received any financial support, or had any financial interest. |
| |
Keywords: | Intravitreal injection Anterior chamber Intraocular lens dislocation Vitreous prolapse Triamcinolone acetonide Complications |
本文献已被 SpringerLink 等数据库收录! |
|